Ginkgo Bioworks Holdings, Inc. (DNA): Nasdaq/NYSE listing notice — Ginkgo Bioworks receives NYSE delisting notice for stock price below $1 for 30 trading days

Ginkgo Bioworks Holdings, Inc.

NYSE notified Ginkgo on May 7, 2024 that average closing price of Class A common stock was below $1.00 over 30 consecutive trading days.
No immediate delisting; six-month cure period to regain compliance by closing at $1.00 or above on last trading day of any calendar month.
Stock continues trading on NYSE under symbol 'DNA' with '.BC' designation indicating non-compliance.
Company intends to regain compliance and is evaluating all available options; business operations unchanged.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Ginkgo Bioworks Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

May 7, 2024, Ginkgo Bioworks Holdings, Inc. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s Class A common stock was less than $1.00 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s Class A common stock from the NYSE. Pursuant to Section 802.01C, the Company has a period of six months from receipt of the notice to regain compliance with the minimum stock price lis

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Ginkgo Bioworks Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-022896

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.